Berberine: A Promising Treatment for Neurodegenerative Diseases

被引:41
作者
Cheng, Ziqian [1 ]
Kang, Chenglan
Che, Songtian
Su, Jingyun [1 ]
Sun, Qihan
Ge, Tongtong
Guo, Yi [1 ]
Lv, Jiayin
Sun, Zhihui [2 ]
Yang, Wei [1 ]
Li, Bingjin
Li, Xin [1 ]
Cui, Ranji [1 ]
机构
[1] Second Hosp Jilin Univ, Jilin Prov Key Lab Mol & Chem Genet, Changchun, Peoples R China
[2] First Hosp Jilin Univ, Dept Pharm, Changchun, Peoples R China
基金
中国国家自然科学基金;
关键词
berberine; neurodegenerative diseases; neuroinflammation; neuroprotection; oxidative stress; MAO-B INHIBITOR; OXIDATIVE STRESS; MUTANT-HUNTINGTIN; TAU HYPERPHOSPHORYLATION; COGNITIVE IMPAIRMENT; MULTIPLE-SCLEROSIS; CEREBRAL-ISCHEMIA; RESEARCH PROGRESS; PC12; CELLS; RAT MODEL;
D O I
10.3389/fphar.2022.845591
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Berberine, as a natural alkaloid compound, is characterized by a diversity of pharmacological effects. In recent years, many researches focused on the role of berberine in central nervous system diseases. Among them, the effect of berberine on neurodegenerative diseases has received widespread attention, for example Alzheimer's disease, Parkinson's disease, Huntington's disease, and so on. Recent evidence suggests that berberine inhibits the production of neuroinflammation, oxidative, and endoplasmic reticulum stress. These effects can further reduce neuron damage and apoptosis. Although the current research has made some progress, its specific mechanism still needs to be further explored. This review provides an overview of berberine in neurodegenerative diseases and its related mechanisms, and also provides new ideas for future research on berberine.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Ageing and neurodegenerative diseases
    Hung, Chia-Wei
    Chen, Yu-Chih
    Hsieh, Wan-Ling
    Chiou, Shih-Hwa
    Kao, Chung-Lan
    AGEING RESEARCH REVIEWS, 2010, 9 : S36 - S46
  • [42] The potential of hyperbaric oxygen as a therapy for neurodegenerative diseases
    Mensah-Kane, Paapa
    Sumien, Nathalie
    GEROSCIENCE, 2023, 45 (02) : 747 - 756
  • [43] Natural products and their active principles used in the treatment of neurodegenerative diseases: a review
    Kamal, Mehnaz
    Naz, Mamuna
    Jawaid, Talha
    Arif, Muhammad
    ORIENTAL PHARMACY AND EXPERIMENTAL MEDICINE, 2019, 19 (04): : 343 - 365
  • [44] Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases
    Gibrat, C.
    Cicchetti, F.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (02) : 380 - 389
  • [45] The Vitamin D Receptor as a Potential Target for the Treatment of Age-Related Neurodegenerative Diseases Such as Alzheimer's and Parkinson's Diseases: A Narrative Review
    Lason, Wladyslaw
    Jantas, Danuta
    Leskiewicz, Monika
    Regulska, Magdalena
    Basta-Kaim, Agnieszka
    CELLS, 2023, 12 (04)
  • [46] Microglial response to aging and neuroinflammation in the development of neurodegenerative diseases
    Han, Tingting
    Xu, Yuxiang
    Sun, Lin
    Hashimoto, Makoto
    Wei, Jianshe
    NEURAL REGENERATION RESEARCH, 2024, 19 (06) : 1241 - 1248
  • [47] Luteolin for neurodegenerative diseases: a review
    Jayawickreme, Dunuvilla Kavindi
    Ekwosi, Cletus
    Anand, Apurva
    Andres-Mach, Marta
    Wlaz, Piotr
    Socala, Katarzyna
    PHARMACOLOGICAL REPORTS, 2024, 76 (04) : 644 - 664
  • [48] The impact of obesity on neurodegenerative diseases
    Mazon, Janaina Niero
    de Mello, Aline Haas
    Ferreira, Gabriela Kozuchovski
    Rezin, Gislaine Tezza
    LIFE SCIENCES, 2017, 182 : 22 - 28
  • [49] The role of thiamine in neurodegenerative diseases
    Bubko, Irena
    Gruber, Beata M.
    Anuszewska, Elzbieta L.
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2015, 69 : 1096 - 1106
  • [50] Neuronal autophagy and neurodegenerative diseases
    Son, Jin H.
    Shim, Jung Hee
    Kim, Kyung-Hee
    Ha, Ji-Young
    Han, Ji Young
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2012, 44 (02) : 89 - 98